Skip to main content
. Author manuscript; available in PMC: 2017 Jun 15.
Published in final edited form as: Biol Psychiatry. 2015 Aug 29;79(12):997–1005. doi: 10.1016/j.biopsych.2015.08.021

Table 1.

All Subject Demographics

Schizophrenia (n=25) Controls (n=18) Statistics
Variable Mean or n SD or % Mean or n SD or % p-value
Age (Years) 34.7 11.3 28.7 8.1 0.060
Education (years) 13.2 1.5 15.4 2.4 0.001*
BMI 30.7 5.1 26.9 5.3 0.020*
NART 109.4 8.5 113.6 7 0.096
FTND 2 2.6 - - -
Injected Activity [mCi] 14.09 3.65 15.68 2.87 0.14
Injected Mass [μg] 3.67 3.22 3.62 3.22 0.95
Specific Activity [mCi/nmol] 3.85 3.57 5.35 4.58 0.23
Free Fraction (fp) 0.001 0.0004 0.001 0.0004 0.16
Antipsychotic Treatment (No/Yes) 7/18 28/72 - - 0.001*
Tobacco Smoker (No/Yes) 14/11 56/44 18/0 100/0 0.410
Race (White/AA/Other) 15/9/1 60/36/4 14/4/0 78/22/0
Ethnicity (Non-Hispanic/Hispanic) 21/4 84/16 14/4 78/22
Lifetime DSM-IV Cannabis Use Disorder 0 0 0 0

BMI: Body Mass Index; NART = National Adult Reading Test; BMI = Body Mass Index; FTND = Fagerstrom Tobacco Test for Nicotine Dependence; AA= African American